Label: GLOVERS DANDRUFF CONTROL MEDICINE, REGULAR- sulfur suspension

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated October 13, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients:

    Sulfur, 2.5%

    Purpose

    Antidandruff

  • Uses:

    Controls scalp itching and flaking due to dandruff

  • Warnings:

    For External Use Only.

    When using this product

    • do not get into eyes. If contact occurs rinse eyes thoroughly with water.

    Stop use and consult a doctor if

    • if skin irritation develops or increases.
    • condition worsens or does not improve after regular use.

    Keep out of reach of children

    If swallowed, get medical help or call a poison control center at once.

  • Directions:

    • Shake well before using.
    • For best results, use at leats twice a week, or as directed  by a doctor.
    • Before shampooimg your hair, apply a small amount to the scalp in several areas. Rub in well. Wait 15 minutes to 1 hour Shampoo thoroughly
  • Inactive Ingredients:

    Mineral Oil (Paraffum Liquidum), Polysorbate-85, Disteardimonium Hectorite, Propylene Glycol, Benzyl Alcohol, Fragrance (Parfum).

  • Package Labeling Bottle

    Bottle

  • Package Labeling:

    Carton

  • INGREDIENTS AND APPEARANCE
    GLOVERS DANDRUFF CONTROL MEDICINE, REGULAR 
    sulfur suspension
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:12022-007
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR25 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    MINERAL OIL (UNII: T5L8T28FGP)  
    POLYSORBATE 85 (UNII: A7F3N56197)  
    DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:12022-007-001 in 1 CARTON09/24/2001
    181 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart358H09/24/2001
    Labeler - J. Strickland & Co. (007023112)
    Registrant - J. Strickland & Co. (007023112)
    Establishment
    NameAddressID/FEIBusiness Operations
    J. Strickland & Co.007023112manufacture(12022-007)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!